In its efforts to share first-hand testimonials from dengue-endemic countries, the Dengue Vaccine Initiative (DVI) asked Dr.

Dr. Capeding led the first Phase 3 trial ever completed for a dengue vaccine candidate.

This blog was originally posed on the Dengue Vaccine Initiative website
 
This year’s Americas Dengue Prevention Board (DPB)

Titled, “New chapter unfolding in the fight against dengue with an unwritten ending,” the Dengue Vaccine Initiative’s (DVI) editorial just published in the October issue of Transactions

Pages